
Saber-C AVIA is a zero-profile construct providing biomechanical stability similar to that of traditional plate systems.
Saber-C AVIA is a zero-profile construct providing biomechanical stability similar to that of traditional plate systems.

Saber-C AVIA is a zero-profile construct providing biomechanical stability similar to that of traditional plate systems.

Smith+Nephew (NYSE:SNN) announced today that the FDA granted de novo clearance for its TESSA spatial surgery system.

The technology offers a dual-sided design with a nonporous underside and porous polyethylene structure on other sides.

NEWNAN, Ga., July 17, 2026 /PRNewswire/ — Poriferous, LLC, a leading global manufacturer of SuᐧPor® craniomaxillofacial and patient-specific implants, has been awarded its patent for its innovative DuraBloc™ technology from the U.S. Patent and Trademark Office (USPTO), U.S. Patent No. 12,653,677, issued on June 16, 2026.

TORONTO, July 15, 2026 /PRNewswire/ — SpinaFX Medical Inc. (“SpinaFX”), a Toronto‑based medical device company specializing in image‑guided, minimally invasive spine care, today announced it has received Medical Device Regulation (MDR) CE Mark certification for its Triojection® System (MDR 843778).

Movmedix announced today that it received FDA 510(k) clearance for its third-generation LARS ACJ synthetic ligament implant platform.

A biodegradable pressure sensor could help people with knee injuries exercise and heal faster, University of Connecticut researchers report in Science Advances. The

LEM Surgical announced today that the FDA granted a new 510(k) clearance for its Dynamis robotic surgical system.

Researchers at The University of Alabama in Huntsville (UAH), a part of The University of Alabama System, have published new findings suggesting continuous low-intensity ultrasound may help shift the body’s immune response from prolonged inflammation toward tissue repair, a discovery that could eventually contribute to novel treatments for joint injuries and post-traumatic osteoarthritis.

The largest and longest clinical trial of its kind has found that resurfacing the kneecap during total knee replacement is likely to be the most cost-effective approach for patients and health care systems over the long term.